These findings underscore a feedback mechanism involving IGF2BP3K76‐lactylation and PCK2‐serine‐SAM that drive PCK2 and NRF2 expression, thereby increasing the antioxidant capacity of lenvatinib‐resistant HCC. This evidence concerns the gene PCK2 and hepatocellular carcinoma.